Cannara Biotech's market cap is currently $112.14M. The company's EPS TTM is $0.028975960000000002; its P/E ratio is 9.89; Cannara Biotech is scheduled to report earnings on July 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
